rs200019422
Variant summary
Our verdict is Pathogenic. Variant got 22 ACMG points: 22P and 0B. PVS1PM2PP3_StrongPP5_Very_Strong
The NM_000255.4(MMUT):c.1560+1G>T variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000458 in 1,528,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000255.4 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 22 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MMUT | NM_000255.4 | c.1560+1G>T | splice_donor_variant | ENST00000274813.4 | |||
MMUT | XM_005249143.4 | c.1560+1G>T | splice_donor_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MMUT | ENST00000274813.4 | c.1560+1G>T | splice_donor_variant | 1 | NM_000255.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000666 AC: 1AN: 150238Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000435 AC: 6AN: 1378608Hom.: 0 Cov.: 27 AF XY: 0.00000290 AC XY: 2AN XY: 689504
GnomAD4 genome AF: 0.00000666 AC: 1AN: 150238Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73282
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 13, 2020 | Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in MUT are known to be pathogenic (PMID: 15781192). For these reasons, this variant has been classified as Pathogenic. This variant has been observed in combination with another MUT variant in several individuals affected with methylmalonic aciduria (PMID: 15643616, 17075691). This variant is not present in population databases (ExAC no frequency). This sequence change affects a donor splice site in intron 8 of the MUT gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. - |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Sep 06, 2017 | - - |
Methylmalonic acidemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 13, 2019 | Variant summary: MUT c.1560+1G>T is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. 5/5 computational tools predict the variant abolishes a 5 prime splicing donor site and a significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 247968 control chromosomes (gnomAD). The variant, c.1560+1G>T, has been reported in the literature in multiple individuals affected with Methylmalonic Acidemia (Cavicchi_2005, Acquaviva_2005, Sakamoto_2007). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One ClinVar submission from other clinical diagnostic laboratories (evaluation after 2014) cites the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at